Understanding Radiation for Prostate Cancer with Limited Spread
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center
This research brings together experts to learn how radiation therapy can help patients with prostate cancer that has spread to only a few spots.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11171427 on NIH RePORTER |
What this research studies
When prostate cancer spreads, it can sometimes go to just a few new areas, a stage called oligometastasis. This project aims to understand how radiation therapy works at the cell, tissue, and organ levels to fight this limited spread. Researchers will use information from clinical trials, biological samples, and advanced computer models to explore these mechanisms. The goal is to discover new and better ways to use radiation to stop prostate cancer from spreading further.
Who could benefit from this research
Good fit: This research is most relevant to patients with prostate cancer that has spread to a limited number of new locations in the body.
Not a fit: Patients whose prostate cancer has not spread or has spread widely to many areas may not directly benefit from this specific research focus.
Why it matters
Potential benefit: If successful, this work could lead to improved radiation treatments that more effectively control or prevent the spread of prostate cancer.
How similar studies have performed: Small randomized studies have shown some success with radiation in recurrent limited spread, but its use in newly diagnosed limited spread is still being explored.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Sawant, Amit — University of Maryland Baltimore
- Study coordinator: Sawant, Amit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.